HCA Investigations No Harm to its Finances
HCA's latest settlement with the DOJ is the latest hit to the for-profit hospital chain, which, just a month ago, disclosed to investors on a second quarter earnings call that it was under a federal investigation by the DOJ for cardiac procedures performed at hospitals in Florida.
On the call, HCA pre-empted a New York Times investigation into its care of the indigent population and payment of ER doctors. That federal probe is ongoing and is unrelated to Wednesday's settlement. HCA stock closed down the day after the August 6th second quarter earnings call, but since then its stock price has risen by $6.96 per share.
"They're in very strong position, financially," says CRT's Skolnick. Perhaps because the company was only released from its eight-year CIA in 2009, she says she doesn't see evidence of a widespread problem at HCA. "The behaviors you learn while someone is watching your every move are hard to shake off," says Skolnick.
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Building a Better Healthcare Board
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Quiet ORs Better for Patient Safety
- CMS Releases Hospital Pricing Data
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Hospital Pricing Data Dump Won't Hurt You, Yet
- Telemedicine is Retail Health Clinics' Newest Tool